Nasdaq Stockholm Welcomes ISR to First North
(WorldNews Denmark)

Nasdaq Stockholm Welcomes ISR to First North Stockholm, March 24, 2017 - Nasdaq (Nasdaq: NDAQ) announces that the trading in ISR Immune System Regulation Holding AB `s shares (short name: ISR) commenced today on Nasdaq First North in Stockholm. ISR belongs to the health care sector and is the 14 company to be admitted to trading on Nasdaq`s Nordic markets* in 2017. ISR Immune System Regulation Holding AB is an innovation driven research company within the area of immunotherapy, based at the Karolinska Institute in Stockholm, Sweden. The Company has a focus on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections. For more...